https://www.galileobio.com/en https://www.galileobio.com https://www.galileobio.com/en/about-us https://www.galileobio.com/sobre-nos https://www.galileobio.com/en/leadership-team https://www.galileobio.com/lideranca https://www.galileobio.com/en/science-technology https://www.galileobio.com/ciencia-tecnologia https://www.galileobio.com/en/pipeline https://www.galileobio.com/pipeline https://www.galileobio.com/en/careers https://www.galileobio.com/carreiras https://www.galileobio.com/en/news https://www.galileobio.com/noticias https://www.galileobio.com/en/contact https://www.galileobio.com/contato https://www.galileobio.com/en/search https://www.galileobio.com/search https://www.galileobio.com/en/news/antharis-therapeutics-acquires-cassyni-biopharma-and-its-portfolio-of-assets https://www.galileobio.com/en/news/antharis-therapeutics-acquires-galileo-biotech-including-its-gmp-certified-development-and-manufacturing-facility https://www.galileobio.com/news/antharis-therapeutics-adquire-cassyni-biopharma-e-seu-portfolio-de-ativos https://www.galileobio.com/news/antharis-therapeutics-adquire-galileo-biotech-incluindo-sua-instalacao-de-desenvolvimento-e-fabricacao-certificada-gmp https://www.galileobio.com/en/news/antharis-therapeutics-announces-successful-completion-of-its-series-a-financing-round https://www.galileobio.com/news/antharis-therapeutics-anuncia-conclusao-bem-sucedida-de-sua-rodada-de-financiamento-serie-a https://www.galileobio.com/en/news/antharis-therapeutics-appoints-patric-nelson-as-chief-business-officer https://www.galileobio.com/en/news/antharis-therapeutics-awarded-biopharmaceutical-company-of-the-year-2024---california-by-global-health-and-pharma https://www.galileobio.com/en/news/antharis-therapeutics-ceo-dr-raphael-ribeiro-pinaud-featured-in-biotech-leader-spotlight-series https://www.galileobio.com/en/news/antharis-therapeutics-ceo-dr-raphael-ribeiro-pinaud-named-among-most-impactful-ceos-of-the-year-2024-by-cio-today https://www.galileobio.com/en/news/antharis-therapeutics-ceo-dr-raphael-ribeiro-pinaud-named-most-inpiring-business-leader-of-2024-by-cxo-outlook-for-pioneering-advances-in-biopharma-innovation https://www.galileobio.com/en/news/antharis-therapeutics-dr-raphael-ribeiro-pinaud-named-most-iconic-business-leader-of-2025 https://www.galileobio.com/news/antharis-therapeutics-dr-raphael-ribeiro-pinaud-nomeado-lider-empresarial-mais-iconico-de-2025 https://www.galileobio.com/en/news/antharis-therapeutics-elected-monoclonal-antibodies-development-company-of-the-year-2025 https://www.galileobio.com/news/antharis-therapeutics-eleita-empresa-do-ano-2025-no-desenvolvimento-de-anticorpos-monoclonais https://www.galileobio.com/en/news/antharis-therapeutics-honored-with-ghp-innovation-excellence-award-of-the-year-2025 https://www.galileobio.com/news/antharis-therapeutics-honrada-com-o-premio-de-excelencia-em-inovacao-ghp-do-ano-2025 https://www.galileobio.com/news/antharis-therapeutics-nomeia-patric-nelson-como-diretor-de-desenvolvimento-de-negocios https://www.galileobio.com/news/antharis-therapeutics-recebe-daniel-yazbeck-como-head-de-estrategia-corporativa https://www.galileobio.com/news/antharis-therapeutics-recebe-o-premio-empresa-biofarmaceutica-do-ano-2024---california-pela-global-health-and-pharma https://www.galileobio.com/en/news/antharis-therapeutics-recognized-as-a-leading-emerging-biopharmaceutical-company https://www.galileobio.com/news/antharis-therapeutics-reconhecida-como-uma-das-principais-empresas-emergentes-no-setor-biofarmaceutico https://www.galileobio.com/news/antharis-therapeutics-selecionada-como-uma-das-10-principais-startups-de-biotecnologia-em-2023-pela-pharma-tech-outlook-por-inovacoes-em-tratamentos-imuno-oncologicos-para-cancer https://www.galileobio.com/en/news/antharis-therapeutics-selected-as-a-top-10-biotech-startup-in-2023-by-pharma-tech-outlook-for-pioneering-immuno-oncological-cancer-treatments https://www.galileobio.com/en/news/antharis-therapeutics-welcomes-daniel-yazbeck-as-head-of-corporate-strategy https://www.galileobio.com/news/ceo-da-antharis-therapeutics-dr-raphael-ribeiro-pinaud-destaque-na-serie-biotech-leader-spotlight https://www.galileobio.com/news/ceo-da-antharis-therapeutics-dr-raphael-ribeiro-pinaud-nomeado-entre-os-ceos-mais-impactantes-do-ano-2024-pela-cio-today https://www.galileobio.com/news/dr-raphael-ribeiro-pinaud-ceo-da-antharis-therapeutics-e-nomeado-lider-empresarial-mais-inspirador-de-2024-pela-cxo-outlook-por-avancos-pioneiros-em-inovacao-biofarmaceutica https://www.galileobio.com/careers/cientista-pos-doutorado-em-biologia-celular https://www.galileobio.com/en/careers/postdoctoral-scientist-in-cellular-biology https://www.galileobio.com/careers/cientista-pos-doutorado-em-engenharia-molecular-de-anticorpos https://www.galileobio.com/en/careers/postdoctoral-scientist-in-molecular-antibody-engineering